Filing metadata

Accession number
0001140361-17-041600
Form type
Form 3
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Nov 08, 2017
Reporting period
Nov 08, 2017
Description
Initial ownership

Explore SEC Filings Hub